Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma

Published:2013-05-15 Issue:7 Volume:30 Page:867-876
ISSN:0262-0898
Container-title:Clinical & Experimental Metastasis
language:en
Short-container-title:Clin Exp Metastasis

Author:

Birkeland Einar,Busch Christian,Berge Elisabet Ognedal,Geisler Jürgen,Jönsson Göran,Lillehaug Johan Richard,Knappskog Stian,Lønning Per Eystein

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10585-013-9587-4.pdf

Reference44 articles.

1. Rigel DS (2008) Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol 58(5 Suppl 2):S129–S132

2. Francken AB, Accortt NA, Shaw HM et al (2008) Follow-up schedules after treatment for malignant melanoma. Br J Surg 95(11):1401–1407

3. Eggermont AM (2006) Reaching first base in the treatment of metastatic melanoma. J Clin Oncol 24(29):4673–4674

4. Akslen LA, Angelini S, Straume O et al (2005) BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. J Investig Dermatol 125(2):312–317

5. Ugurel S, Thirumaran RK, Bloethner S et al (2007) B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis. PLoS ONE 2(2):e236

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating Therapeutic Efficacy of Dacarbazine and Temozolomide, Alone and in Combination with BRAF(V600E) siRNA in A375 Human Melanoma Cell Line;2024-04-03

2. Bacillus Calmette–Guérin Immunotherapy for Cancer;Vaccines;2021-05-01

3. Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated;Journal of Translational Medicine;2020-05-11

4. BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis;Acta Oncologica;2020-04-14

5. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway;Journal of Investigative Dermatology;2020-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3